Impedimed (ASX:IPD) Other Current Liabilities: A$4.12 Mil (As of Dec. 2025)


What is Impedimed Other Current Liabilities?

Impedimed ASX:IPD +20.00% Other Current Liabilities is A$4.12 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Impedimed's other current liabilities for the quarter that ended in Dec. 2025 was A$4.12 Mil.

Impedimed's quarterly other current liabilities increased from Dec. 2024 (A$3.14 Mil) to Jun. 2025 (A$3.85 Mil) and increased from Jun. 2025 (A$3.85 Mil) to Dec. 2025 (A$4.12 Mil).

Impedimed's annual other current liabilities declined from Jun. 2023 (A$3.32 Mil) to Jun. 2024 (A$2.72 Mil) but then increased from Jun. 2024 (A$2.72 Mil) to Jun. 2025 (A$3.85 Mil).

Impedimed Other Current Liabilities Related Terms

Impedimed Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Impedimed's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Impedimed Other Current Liabilities Chart

Impedimed Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.07 3.85 3.32 2.72 3.85

Impedimed Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.12 2.72 3.14 3.85 4.12

Impedimed Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of A$4.12 Mil mean?
Impedimed (ASX:IPD) has a Other Current Liabilities of A$4.12 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Impedimed.
Is Impedimed's Other Current Liabilities too high?
Impedimed's current Other Current Liabilities is A$4.12 Mil.
How does Impedimed's Other Current Liabilities compare to ABT and SYK?
Impedimed's Other Current Liabilities of A$4.12 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Impedimed. Impedimed's current Other Current Liabilities is A$4.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impedimed stock overvalued right now?
Based on GuruFocus' analysis, Impedimed (ASX:IPD) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.08, compared to a current price of A$0.01 — trading 92.5% below its estimated fair value. The current Other Current Liabilities is A$4.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Impedimed (ASX:IPD), the current Other Current Liabilities is A$4.12 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Impedimed Business Description

Other Exchanges IPDQF:USA
Address 5900 Pasteur Court, Suite 125, Carlsbad, CA, USA, 92008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.